Pharmafile Logo
Pharmafocus logo
Advanced Search

johnson

Showing 15 posts of 16 posts found.

nhs_sign

Few in NHS trust tech firms handling patient data

November 29, 2019
Medical Communications AI, Boris, Corbyn, NHS, NHS Brexit, johnson

Few in the NHS trust ‘big tech’ companies to handle patient data in a confidential manner, a recent YouGov poll …

News
J&J image

J&J hands over compassionate use reviews to academics

May 7, 2015
Sales and Marketing J&J, JJ, academics, compac, eap, johnson

Johnson & Johnson has struck a ‘first-of-its-kind partnership’ with academic researchers to review requests for compassionate use of its investigational …

News
Gilead image

Gilead expands UK presence with new London HQ

February 10, 2015
Research and Development, Sales and Marketing Cambridge, Gilead, London, NICE, UK, johnson, medcity, sovaldi, uxbridge

Gilead is to create a new UK commercial secondary headquarters in central London doubling its UK workforce to 600 by …

News
J&J image

J&J leukaemia drug gets FDA go-ahead

January 30, 2015
Sales and Marketing FDA, J&J, JJ, Janssen, The US Food and Drug Administration has shown Janssen’s leukaemia drug Imbruvica the green light to treat patients with waldenström’s macroglobulinemia (WM) – a rare indol, Waldenström’s Macroglobulinemia, ibrutinab, imbruvica, johnson

The US Food and Drug Administration has shown Janssen’s leukaemia drug Imbruvica the green light to treat patients with waldenström’s …

News
Janssen image

Vectura and J&J shake on asthma/COPD deal

January 6, 2015
Research and Development, Sales and Marketing COPD, J&J, JJ, Janssen, asthma, johnson, rezolsta, tybost, vectura

British firm Vectura has entered an agreement with Johnson & Johnson’s pharma unit Janssen to develop therapies for asthma and …

News
Ebola image

UK nurse with Ebola in ‘critical condition’

January 6, 2015
Research and Development, Sales and Marketing Africa, Ebola, GSK, Mapp, WHO, cafferky, johnson, zmapp

A British nurse that was diagnosed with Ebola last week is said to be in a critical condition at the …

News
GSK image

GSK Ebola vaccine gets EU support

December 17, 2014
Research and Development, Sales and Marketing EC, EU, Ebola, Europe, GSK, Merck, Takeda, Vaccine, WHO, johnson

A newly-formed European consortium is to help advance the development of GlaxoSmithKline’s promising Ebola vaccine. The consortium is backed by …

News
Dendreon image

Dendreon files for bankruptcy

November 12, 2014
Research and Development, Sales and Marketing Dendreon, Provenge, awick, delaware, johnson, nj

Dendreon Corporation, the troubled manufacturer of high-cost cancer vaccine Provenge, has filed for bankruptcy as a prelude to restructuring its …

News
J&J image

J&J announces ‘major commitment’ to Ebola effort

October 22, 2014
Sales and Marketing Crucell, Ebola, J&J, JJ, Vaccine, bavarian, johnson, niaid

Johnson & Johnson will invest $200 million to accelerate and significantly expand the production of its Ebola vaccine programme. The …

News
GSK image

GSK Ebola vaccine underway

August 11, 2014
Research and Development, Sales and Marketing Africa, Ebola, GSK, Vaccine, WHO, johnson

Clinical trials of an experimental vaccine against the deadly Ebola virus will begin soon according to its developers GlaxoSmithKline. The …

News
Medicity image

MediCity hub moves forward

June 11, 2014
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, BioCity, alderley park, johnson, medcity, medicity

 Nine new businesses have signed tenancy agreements at Nottingham’s MediCity, bringing to 20 the number of companies which have been …

News

New biomedical engineering centre for Imperial

May 28, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Cambridge, imperial college london, johnson, medcity, uren

Imperial College London is to build a pioneering biomedical engineering centre that will cement London and the south east’s reputation …

News
Zytiga image

NICE: no early Zytiga use

May 14, 2014
Sales and Marketing Cancer, Janssen, NHS, NICE, Zytiga, johnson, prostate

Janssen has criticised NICE’s decision not to recommend Zytiga on the NHS at an earlier stage in the prostate cancer …

News

Major new launches for 2014

March 17, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AZ, AbbVie, Big Pharma, Merck, Novartis, Pfizer, Roche, Sanofi, ask, johnson, lilly, top 10

 AbbVie AbbVie needs a blockbuster to eventually replace its flagship Humira – and is hoping its new hepatitis C treatments …

Feature
J&J image

J&J reveals more on transparency policy

February 3, 2014
Medical Communications, Research and Development, Sales and Marketing Goldacre, J&J, JJ, alltrials, johnson, transparency, yoda

Johnson & Johnson’s pharma subsidiary Janssen has given Pharmafile more details on its new transparency policy, which will see both …

News

Latest content

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024

PeptiDream and Novartis extend peptide discovery collaboration

April 30, 2024

Pfizer’s Beqvez approved by FDA for haemophilia B treatment

April 29, 2024